Pyoderma gangrenosum: Successful topical treatment with tacrolimus (FK 506);Pyoderma gangraenosum: Erfolgreiche topische therapie mit tacrolimus (FK506)

Hautarzt

Volumn 52, Issue 1, 2001, Pages 47-50

  Petering, H ^a   Kiel, P ^a   Breuer, C ^a   Kapp, A ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Pyoderma gangrenosum; Tacrolimus; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; STEROID; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG POTENCY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE ACTIVATION; PATHOGENESIS; PYODERMA GANGRENOSUM; SKIN PENETRATION; STEROID THERAPY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ABDOMEN; ADULT; COLITIS, ULCERATIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; PYODERMA GANGRENOSUM; TACROLIMUS; TIME FACTORS;

EID: 0035129118     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051261     Document Type: Article

References (25)

1. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum
2. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum
3. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment
4. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occuring in adults
5. Resolution of pyoderma gangrenosum using tacolimus (FK-506)
6. Pyoderma gangrenosum treated with cyclosporin A
7. EK-506 and cyclosporin A: Selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation
8. Pyoderma gangrenosum: A reappraisal of associated systemic diseases
9. Pyoderma gangrenosum: Clinical and laboratory findings in 15 patients with special reference to polyarthritis
10. Das Pyoderma gangraenosum
11. Current concepts: Immunology. Neutrophils in human diseases
12. Treatment of pyoderma gangrenosum with cyclosporine
13. Pyoderma gangrenosum
14. Present status of pyoderma gangrenosum. Review of 21 cases
15. Topical tacrolimus for pyoderma gangrenosum
16. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation
17. Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum
18. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation
19. Treatment of pyoderma gangrenosum with methotrexate
20. Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
21. Successful topical administration of cyclosporin A in pyoderma gangraenosum
22. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
23. Pyoderma gangrenosum: A report of 44 cases with follow-up
24. Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum
25. Low dosage cyclosporin A therapy in pyoderma gangrenosum. Experiences with 6 patients